We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax Can Launch Generic Renvela, Renagel in 2014 Under Genzyme Deal
Impax Can Launch Generic Renvela, Renagel in 2014 Under Genzyme Deal
September 11, 2012
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.